WATERLOO, NY, UNITED STATES, February 16, 2026 /EINPresswire.com/ -- Heritage Structures, a family-owned manufacturer ...
Structure Therapeutics Inc. is emerging in oral GLP-1 obesity drugs after Phase II success and rivals’ setbacks. Click here ...
Some people say flat structures cause chaos in organizations. And while that can certainly be true, my experience has been different. After years of working for horizontal and vertical hierarchies, I ...
In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics. The agreement grants Roche and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results